Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Hagit Eldar-Finkelman"'
Autor:
Dorit Farfara, Meital Sooliman, Limor Avrahami, Tabitha Grace Royal, Shoshik Amram, Lea Rozenstein-Tsalkovich, Dorit Trudler, Shani Blanga-Kanfi, Hagit Eldar-Finkelman, Jens Pahnke, Hanna Rosenmann, Dan Frenkel
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-15 (2023)
Abstract Background Alzheimer’s disease (AD) is the leading cause of dementia in the world. The pathology of AD is affiliated with the elevation of both tau (τ) and β-amyloid (Aβ) pathologies. Yet, the direct link between natural τ expression o
Externí odkaz:
https://doaj.org/article/36f940c1cd774042b9dbd3ca9047e489
Autor:
Hagit Eldar-Finkelman
Publikováno v:
Expert Opinion on Therapeutic Targets. 10:199-201
Dr Hagit Eldar-Finkelman (Sackler School of Medicine, Israel) was interviewed by Emma Quigley (Commissioning Editor, Expert Opinion on Therapeutic Targets) on 16th February 2006. Born in Jerusalem, Dr Eldar-Finkelman received her BSc in Chemistry in
Autor:
Amnon Wittenstein, Michal Caspi, Ido Rippin, Orna Elroy-Stein, Hagit Eldar-Finkelman, Sven Thoms, Rina Rosin-Arbesfeld
Publikováno v:
PLoS Biology, Vol 21, Iss 11, p e3002355 (2023)
The introduction of premature termination codons (PTCs), as a result of splicing defects, insertions, deletions, or point mutations (also termed nonsense mutations), lead to numerous genetic diseases, ranging from rare neuro-metabolic disorders to re
Externí odkaz:
https://doaj.org/article/326ee8ebb9fd4674935f832a707e601c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eldar-Finkelman H
Publikováno v:
Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2006 Apr; Vol. 10 (2), pp. 199-201.
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
Glycogen synthase kinase-3 (GSK-3) is a highly conserved serine/threonine protein kinase that plays a central role in a wide variety of cellular processes, cognition and behaviour. In a previous study we showed that its α and β isozymes are highly
Externí odkaz:
https://doaj.org/article/3b014bb0a18743af95c2b8b70997e9ae
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2022)
The protein kinase, GSK-3, participates in diverse biological processes and is now recognized a promising drug discovery target in treating multiple pathological conditions. Over the last decade, a range of newly developed GSK-3 inhibitors of diverse
Externí odkaz:
https://doaj.org/article/c86fe7868f0b41eabe4de6be5ca39431
Autor:
Ido Rippin, Katherina Bonder, Shirley Joseph, Ammar Sarsor, Lilach Vaks, Hagit Eldar-Finkelman
Publikováno v:
Neurobiology of Disease, Vol 154, Iss , Pp 105336- (2021)
In Huntington's disease (HD), the mutant huntingtin (mHtt) accumulates as toxic aggregates in the striatum tissue, with deleterious effects on motor-coordination and cognitive functions. Reducing the levels of mHtt is therefore a promising therapeuti
Externí odkaz:
https://doaj.org/article/046c34e9ec654364a9ccf8bd0fb54142
Publikováno v:
Cells, Vol 11, Iss 10, p 1618 (2022)
Over the last decade, there has been continuous progress in our understanding of the biology of the protein kinase GSK-3 [...]
Externí odkaz:
https://doaj.org/article/f2c894619e724a4a89f220efaa992334
Autor:
Nadav Elkoshi, Shivang Parikh, Hagar Malcov-Brog, Roma Parikh, Paulee Manich, Francesca Netti, Avishai Maliah, Hana Elkoshi, Majd Haj, Ido Rippin, Jacob Frand, Tomer Perluk, Rivi Haiat-Factor, Tamar Golan, Neta Regev-Rudzki, Edo Kiper, Ronen Brenner, Pinchas Gonen, Iris Dror, Hagai Levi, Ofir Hameiri, Mazal Cohen-Gulkar, Hagit Eldar-Finkelman, Gil Ast, Eran Nizri, Yael Ziv, Rani Elkon, Mehdi Khaled, Yuval Ebenstein, Yosef Shiloh, Carmit Levy
Publikováno v:
Journal of Investigative Dermatology.